Prolia is a Subcutaneous Injection in the Human Prescription Drug category. It is labeled and distributed by Amgen Inc. The primary component is Denosumab.
Product ID | 55513-710_1dc757ce-c06c-4669-ad85-35181469b2ed |
NDC | 55513-710 |
Product Type | Human Prescription Drug |
Proprietary Name | Prolia |
Generic Name | Denosumab |
Dosage Form | Injection |
Route of Administration | SUBCUTANEOUS |
Marketing Start Date | 2010-06-05 |
Marketing Category | BLA / BLA |
Application Number | BLA125320 |
Labeler Name | Amgen Inc |
Substance Name | DENOSUMAB |
Active Ingredient Strength | 60 mg/mL |
Pharm Classes | RANK Ligand Inhibitor [EPC],RANK Ligand Blocking Activity [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2010-06-05 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | BLA |
Application Number | BLA125320 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2010-06-05 |
Ingredient | Strength |
---|---|
DENOSUMAB | 60 mg/mL |
SPL SET ID: | 49e5afe9-a0c7-40c4-af9f-f287a80c5c88 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
55513-710 | Prolia | denosumab |
55513-730 | XGEVA | denosumab |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
PROLIA 78333153 3399344 Live/Registered |
Cargill, Incorporated 2003-11-25 |
PROLIA 77350521 3848203 Live/Registered |
Amgen Inc. 2007-12-12 |
PROLIA 75432744 2643134 Dead/Cancelled |
Amgen Inc. 1998-02-11 |
PROLIA 75342787 not registered Dead/Abandoned |
Amgen Inc. 1997-08-18 |